This is why I like that Eltop was not in the final deal with EMOR.

And why I think it will be or could be very good for both moving forward.
https://m.investorshangout.com/post/view?id=5827495

Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease
https://www.globenewswire.com/en/news-release...sease.html


Emerald Organic Products, Inc. Announces Exclusive Licensing Agreement With PetVivo Holdings Inc.
https://petvivo.com/blogs/news/emerald-organi...ldings-inc

The connection is there.
The possibility is there.
Is the science there?
It's looking like it is.
Is the money there?


If ths is a remote possibility in institution eyes well that would change things quickly.

Same with LymPro and Todos & AMBS.
And it's looking like it's going that direction in the 2H.

We'll see.